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Quinone binding siteThe Escherichia coli respiratory complex II paralogs succinate dehydrogenase (SdhCDAB) and fumarate reduc-
tase (FrdABCD) catalyze interconversion of succinate and fumarate coupled to quinone reduction or oxida-
tion, respectively. Based on structural comparison of the two enzymes, equivalent residues at the interface
between the highly homologous soluble domains and the divergent membrane anchor domains were
targeted for study. This included the residue pair SdhB-R205 and FrdB-S203, as well as the conserved
SdhB-K230 and FrdB-K228 pair. The close proximity of these residues to the [3Fe–4S] cluster and the quinone
binding pocket provided an excellent opportunity to investigate factors controlling the reduction potential of
the [3Fe–4S] cluster, the directionality of electron transfer and catalysis, and the architecture and chemistry
of the quinone binding sites. Our results indicate that both SdhB-R205 and SdhB-K230 play important roles in
ﬁne tuning the reduction potential of both the [3Fe–4S] cluster and the heme. In FrdABCD, mutation of
FrdB-S203 did not alter the reduction potential of the [3Fe–4S] cluster, but removal of the basic residue at
FrdB-K228 caused a signiﬁcant downward shift (>100 mV) in potential. The latter residue is also indispens-
able for quinone binding and enzyme activity. The differences observed for the FrdB-K228 and Sdh-K230 var-
iants can be attributed to the different locations of the quinone binding site in the two paralogs. Although this
residue is absolutely conserved, they have diverged to achieve different functions in Frd and Sdh.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Escherichia coli is a versatile facultative anaerobe. During aerobic
growth, the respiratory enzyme succinate dehydrogenase (SdhCDAB)
mediates electron transfer (ET) from succinate to ubiquinone (UQ)
and thus plays a pivotal role in the ET chain and oxidative phosphoryla-
tion. Under anaerobic conditions, the paralog fumarate reductase
(FrdABCD) acts as an electron sink to regenerate menaquinone (MQ)
by utilizing fumarate as the terminal electron acceptor in lieu of oxygen.
Three dimensional crystal structures of these two paralogs show that
they share an overall architecture wherein the soluble SdhAB/FrdAB di-
mers are anchored to the inner surface of the cytoplasmicmembrane byramagnetic resonance; ET, elec-
scence quench; FrdABCD, fuma-
tyl-4-hyroxyquinoline-N-oxide;
e; Q-site, quinone binding site;
duced ubiquinone
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rights reserved.their respective hydrophobic anchors, SdhCD or FrdCD [1–3]. Coupling
of the succinate–fumarate and quinone–quinol reactions is achieved
via the ET relay, which consists of a ﬂavin adenine dinucleotide (FAD)
in SdhA/FrdA and three [Fe–S] clusters in SdhB/FrdB [4,5]. In the case
of SdhCDAB, a heme moiety in the membrane intrinsic domain may
also partake in electron transfer, but its incorporation into the holoen-
zyme is not essential for function [6].
Superimposition of the three-dimensional structures of SdhCDAB
(PDB: 1NEK) and FrdABCD (PDB: 1KF6) shows that the dicarboxylate
binding site, the FAD cofactor, and the [Fe–S] clusters have essentially
identical spatial arrangements (RMSD = 1.69 Å for subunit A, 1.75 Å
for subunit B) (Fig. 1A). Despite the high level of similarity observed be-
tween SdhAB and FrdAB, there are subtle differences in sequence and
biophysical properties of the cofactors that determine the directionality
of enzyme function (i.e., succinate oxidation coupled to quinone reduc-
tion versus quinol oxidation coupled to fumarate reduction). For in-
stance, the equivalent, but non-conserved, SdhA-Q50 and FrdA-E49
residues dictate dicarboxylate oxidation or reduction by exerting a cou-
lombic effect on the electronic state of the FAD cofactor [7]. In SdhB, the
native reduction potentials (Em values) of the [2Fe–2S], [4Fe–4S] and
[3Fe–4S] clusters are +10 mV, −175 mV and +65 mV respectively,
and thus favor electron ﬂow towards the quinone-binding site
BA
Fig. 1. (A) Superimposition of E. coli SdhCDAB (green) and FrdABCD (orange). The paralogs share similar architectures of the electron transfer relay and the soluble domains. The
FAD molecule is represented by sticks and the iron–sulfur clusters (from top to bottom: [2Fe–2S], [4Fe–4S] and [3Fe–4S]) are drawn in spheres. (B) The residues examined in this
study are in close proximity to the quinone binding sites and the [3Fe–4S] cluster in Sdh and Frd. In both panels, the two views were generated after a three-dimensional alignment
of SdhCDAB (PDB: 1NEK, co-crystallized with native UQ) with FrdABCD (PDB: 1KF6, co-crystallized with exogenous HOQNO, a menasemiquinone analog that acts as a competitive
Q-site inhibitor) using PyMOL v.1.2r1 (DeLano Scientiﬁc LLC.).
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poised ([2Fe–2S], −20 mV; [4Fe–4S], −320 mV; [3Fe–4S], −70 mV)
[10,11] such that ET from the Q-site to the FAD is favored. The residue
pair SdhB-H207/FrdB-T205 was recently demonstrated to contribute
to the high and low reduction potentials of the [3Fe–4S] cluster in
SdhCDAB and FrdABCD, respectively [12]. An additional level of catalyt-
ic control is exerted by the type of quinone preferentially utilized by the
two paralogs. The Em of the succinate/fumarate couple is +30 mV. The
higher Em value of +110 mV for the UQ/UQH2 transition ensures that
electrons ﬂow away from the FAD in Sdh whereas the lower Em value
of −74 mV for the MQ/MQH2 transition directs electrons towards the
FAD in Frd [4]. Finally, catalysis may also be controlled by the type of
subunits assembled. In Ascaris suum, the mitochondrial complex II
may act as either a Sdh or Frd depending on the stage of parasitic life
cycle and which subunits are expressed [13,14]. Recently, the direction
of electron transfer was also shown to be crucial for mitochondrial
energy production in tumor microenvironments wherein complex II
behaves like a fumarate reductase [15].
A number of factors have been suggested to govern [Fe–S] cluster Em
values, including (i) the local H-bonding network; (ii) the local electro-
static ﬁeld, (iii) solvent accessibility, (iv) backbone amides and (v) the
type of amino acid residues coordinating the cluster [9,16–22]. As point-
ed out above, the structures of SdhCDAB and FrdABCD are essentially
identical, especially in the regions encompassing the ET relay connecting
the dicarboxylate substrate and their respective Q-sites. Differences in
reduction potentials observed for the [Fe–S] clusters in SdhB and FrdB
must arise due to the differences in the environments surrounding the
individual clusters. The overall similarity between the [Fe–S] subunits
and enzymes makes them ideal model systems to study the effects of
cluster environments on observed Em values.
In this study, we examined residues that are located at the interface
between the soluble and membrane anchor domains, and also in
close proximity to the [3Fe–4S] cluster and the Q-site: SdhB-R205
and SdhB-K230, as well as the equivalent residues FrdB-S203 and
FrdB-K228 (Fig. 1B). Using a combination of site-directed mutagenesis,
redox potentiometry, electron paramagnetic resonance (EPR) spectros-
copy and kinetic analysis, we probed how protein modulation of
cofactor Em value is achieved andwhether this affected enzyme catalysis.Our results extend upon a previous study that showed FrdB-K228 is a
critical residue required for Q-binding and oxidation/reduction [23],
and we elaborate here on its inﬂuence on the Em value of the [3Fe–4S]
cluster.2. Materials and methods
2.1. Strains, plasmids and mutagenesis
E. coli laboratory strain TG1 (supE hsdΔ5 thi Δ (lac-proAB) F′[traD36
proAB+ lacIq lacZΔM15]; GE Healthcare) was used for mutagenesis.
Strain DW35 (ΔfrdABCD, sdhC::kan) [24] was used for all enzyme
expression and growth studies. Expression of SdhCDAB and FrdABCD
variants was anaerobically induced by using the plasmids pFAS and
pH3, respectively [25,26]. Mutations were constructed using primers
from Qiagen and the QuikChange protocol from Stratagene. All recom-
binant plasmids were veriﬁed by DNA sequencing.2.2. Enzyme expression and preparation
E. coli strain DW35 harboring the different sdhCDAB or frdABCD
constructs was grown for 16 h at 37 °C in Terriﬁc broth, using a 1%
starting inoculum, with appropriate antibiotics. Isolated membranes
enriched in either enzyme were prepared by repeated passage
through an Avestin Emulsiﬂex for cell lysis followed by differential
ultracentrifugation to isolate the cytoplasmic membrane [6]. All
ﬁnal membrane preparations containing activated enzymes were
suspended in 100 mM MOPS/5 mM EDTA/1 mM malonate at pH 7.2.3. Growth studies
Aerobic growth on succinate and anaerobic growth on glycerol–
fumarate (G–F) were carried out as previously described [27,28]. A
Klett-Summerson colorimeter equipped with a no. 66 ﬁlter was
used to monitor bacterial growth.
Table 1
Hydrogen bonding partners for residues examined in present study. H-bonds listed are
between the side chains of the residues in question and the indicated partners. PDB
ﬁles 1NEK and 1KF6 were used to analyze Sdh and Frd structures, respectively [2,3].
Residue H-bond partner Distance (Å)




SdhB-K230 Backbone C_O, SdhB-C206 3.1
HOH351 3.0
HOH313 2.8
FrdB-S203 Nδ2, FrdB-N164 2.8
FrdB-K228 Backbone C_O, FrdB-C204 3.1
Oε1, FrdB-Q225 2.7
O4, HOQNO 3.1
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Protein concentrations were estimated by the Lowry method [29]
with the inclusion of 1% (w/v) sodium dodecyl sulfate in the mixture
[30]. 30 μg of protein was resolved on a 12% SDS-PAGE gel and visu-
alized by Coomassie blue staining. Fluorometric quantiﬁcation of the
covalent ﬂavin of Sdh was carried out in triplicate as described [31],
using 5 mg of protein as starting material.
2.5. Enzyme assays
Succinate dependent reduction of MTT (2-(4,5-dimethyl-2-
thiazolyl)-3,5-diphenyl-2H-tetrazolium bromide; ε = 17 mM−1 cm−1)
was measured spectrophotometrically at 570 nm in the presence of
750 μM PMS (phenazine methosulfate) and 0.1% Triton X-100 [32].
Succinate-dependent reduction of Q0 (2,3-dimethoxy-5-methyl-
1,4-benzoquinone; ε = 0.73 mM−1 cm−1) and fumarate-dependent
oxidation of lapachol (LPCH; 2-hydroxy-3-(3-methyl-2-butenyl)-
1,4-naphthoquinone; ε = 2.66 mM−1 cm−1), were monitored at
410 nm and 481 nm, respectively. Turnover numbers were calculated
based on covalent ﬂavin concentrations. All assays were carried out
using isolated membranes enriched in SdhCDAB or FrdABCD.
2.6. HOQNO ﬂuorescence quench (FQ) titrations
2-n-Heptyl-4-hyroxyquinoline-N-oxide (HOQNO) binding was
monitored by ﬂuorescence according to Van Ark and Berden [33].
2 μL aliquots of 0.1 mM HOQNO were added to the sample, and ﬂuo-
rescence was measured at an excitation wavelength of 341 nm and
an emission wavelength of 479 nm. Titrations were performed at pro-
tein concentrations of 0.50, 0.75, and 1.00 mg mL−1. The concentra-
tion of HOQNO binding sites and the dissociation constant of
HOQNO were estimated by ﬁtting the data according to Okun et al.
[34,35]. The number of dissociable inhibitor binding sites for FrdABCD
was assumed to be 1 [34,36]. The dissociation constants for HOQNO
binding were not determined for SdhCDAB as HOQNO does not bind
with high afﬁnity to SdhCDAB.
2.7. Redox titrations and EPR spectroscopy
Redox titrationswere carried out anaerobically under argon at 25 °C
on SdhCDAB or FrdABCD-enriched membranes at a total protein con-
centration of approximately 30 mg mL−1 in 100 mM MOPS/5 mM
EDTA (pH 7.0). The following redox mediators were used at a
concentration of 25 μM: quinhydrone, 2,6-dichloroindophenol,
1,2-naphthoquinone, toluylene blue, phenazine methosulfate,
thionine, duroquinone, methylene blue, resoruﬁn, indigotrisulfonate,
indigodisulfonate, anthraquinone-2-sulfonic acid, phenosafranine,
benzyl viologen, and methyl viologen. EPR spectra were recorded
using either a Bruker Elexsys E500 or a Bruker ESP300 EPR spectrometer
each equipped with an Oxford Instruments ESR900 ﬂowing helium
cryostat. The spectra of the [3Fe–4S] cluster were determined at 12 K
while that of heme b were determined at 9 K, both at a microwave
power of 20 mW, a frequency of 9.38 GHz, and amodulation amplitude
of 10 Gpp at 100 kHz. Presented data were gathered from two indepen-
dent potentiometric titrations for each variant enzyme.
3. Results
3.1. Variant enzyme design and expression
Comparison of the E. coli SdhCDAB X-ray crystallographic structure
with endogenous UQ bound (PDB: 1NEK) [3] with that of FrdABCD
with themenasemiquinone HOQNO bound (PDB: 1KF6) [2] reveals dis-
tinct differences between the two paralogs at the interface between the
electron transfer subunit and the membrane intrinsic dimer. Fig. 1Bshows the difference in Q-site orientation relative to the [3Fe–4S] clus-
ters between the two enzymes. The guanidinium moiety of SdhB-R205
is oriented towards the SdhCDAB Q-site, while the Nε-amide of
FrdB-K228 points towards both the Frd quinone-binding site and the
backbone carbonyl oxygen of FrdB-C204. Table 1 lists the residues ex-
amined in this study, along with their potential H-bonding partners.
The Lys residue is conserved between both enzymes, while FrdB-S203
is equivalent to SdhB-R205. Reciprocal mutations were made at the
SdhB-R205/FrdB-S203 position to determine whether residues at this
position play a role in deﬁning the [3Fe–4S] cluster reduction potential
and/or bias for quinone reduction or quinol oxidation in the two
enzymes. The conserved Lys residue was also examined using the sub-
stitutions FrdB-K228R, FrdB-K228E, FrdB-K228L and SdhB-K230L.
SDS-PAGE and covalent ﬂavin analyses on SdhCDAB and FrdABCD-
enriched membranes indicated that all variant enzymes were
overexpressed, assembled, and correctly targeted to the cytoplasmic
membrane (Supplemental Fig. 1).
3.2. Growth experiments
The in vivo activities of the variant enzymes were examined by
monitoring their abilities to support growth in minimal medium
(Fig. 2). The parent strain, DW35, lacks functional SdhCDAB and
FrdABCD and therefore did not grow aerobically with succinate as
electron donor nor anaerobically with G–F as the donor–acceptor
pair [24]. Overexpression of SdhCDAB in DW35 resulted in better
growth on succinate whereas overexpression of FrdABCD led to better
growth on G–F. This was expected based on previous ﬁndings [26].
Fig. 2A shows that Sdh enzymes containing the point mutations
SdhB-R205S and SdhB-K230L were able to support aerobic respirato-
ry growth on succinate at a rate similar to the WT enzyme. The Frd
constructs carrying the FrdB-S203R and FrdB-K228R mutations were
also able to support growth on succinate. However, mutation of
FrdB-K228 to Glu or Leu abolished the ability to complement growth.
Differences in growth were more apparent when the cells were
forced to respire anaerobically on G–F (Fig. 2B). FrdB-S203R was the
only variant that supported comparable growth on G–F relative to
the WT Frd enzyme. The SdhB-R205S, FrdB-K228E and FrdB-K228L
variants did not support growth on G–F, but limited growth was ob-
served when DW35 cells expressed the SdhB-K230L or FrdB-K228R
variant enzymes.
3.2.1. Enzyme activity
The non-physiological succinate:PMS/MTT assay, which measures
enzymatic succinate oxidation activity and only requires the functional
SdhAB or FrdAB domain, is an excellent reporter assay for correct
enzyme assembly. Table 2 shows that all membrane preparations
containing the Sdh and Frd variants had signiﬁcant succinate:PMS/MTT
Fig. 2. Growth of E. coli DW35 complemented with plasmids encoding wild-type and
variant enzymes. Aerobic growth on succinate minimal medium (A) and anaerobic
growth on glycerol–fumarate minimal medium (B) were examined. Growth curves
were collected from two separate and independent bacterial cultures at the times
indicated.
1144 V.W.T. Cheng et al. / Biochimica et Biophysica Acta 1827 (2013) 1141–1147activities, indicating that the mutations in SdhB/FrdB did not disrupt en-
zyme targeting and assembly to the cytoplasmicmembrane. Interesting-
ly, the SdhB-K230L variant had a succinate:PMS/MTT turnover rate that
was approximately 80% higher than theWT Sdh enzyme.
Measurements of succinate-dependent reduction of Q0 (succinate:
Q0 oxidoreductase activity) and fumarate-dependent oxidation of
lapachol (LPCH:fumarate oxidoreductase assay) address the ability of
the variant enzymes to perform catalysis with quinones in opposing
directions (Table 2). In both assays, the SdhB-K230L variant showed
catalytic values that were comparable to the WT Sdh enzyme. TheTable 2
Steady-state kinetics and HOQNO binding of variant enzymes. In the succinate:PMS/MTT a
presence of 750 μM PMS. In the succinate:Q0 and lapachol:fumarate assays, rates of Q0 redu
analog. kcat and Km values were obtained by plotting v against [S] and ﬁtted to the Michaelis
lapachol concentrations. In HOQNO titrations, Frd enzymes were titrated with increasing a
protein concentrations of 0.50 mg mL−1, 0.75 mg mL−1 and 1.00 mg mL−1 such that the c
b10% of reported value. ND: not determined.
Succinate:PMS/MTT Succinate:Q0
kcat (s−1) kcat (s−1) K
WT Sdh 13.4 33.9 0
SdhB-R205S 17.4 15.0 0
SdhB-K230L 24.5 35.6 0
WT Frd 6.6 7.1 0
FrdB-S203R 8.6 6.3 0
FrdB-K228E 4.4 0.7 N
FrdB-K228L 5.4 0.6 N
FrdB-K228R 7.3 5.5 0reciprocal variants SdhB-R205S and FrdB-S203R both retained signiﬁ-
cant catalytic activities (>40% of respective WT enzymes). The most
signiﬁcant decreases in catalytic function were observed in the
FrdB-K228E and FrdB-K228L variants, which had approximately 10%
of WT succinate:Q0 activity but negligible LPCH:fumarate activity.
The related variant, FrdB-K228R, retained ~80% of WT enzyme activity
in the succinate:Q0 assay but had negligible LPCH:fumarate activity.
If a quinone analog with a 2-isoprenoid side chain (Q2) was used,
the membrane-bound FrdB-K228R enzyme retained 43% of its
succinate-Q2 oxidoreductase activity, in reasonable agreement with the
Q0-analog. However, if the membranes were treated with even a small
amount (0.006%) of Triton X-100, the FrdB-K228R enzyme lost measur-
able activity within 10 min, suggesting that the stability of the enzyme
had been compromised in this variant.
3.3. HOQNO binding
We examined the quinone binding afﬁnities of the FrdB variants
by carrying out FQ titrations of the enzyme using the menaquinol an-
alog HOQNO. This compound ﬂuoresces in the unbound state and
when bound to the protein, its ﬂuorescence is quenched. Membrane
preparations from DW35 cells devoid of Sdh and Frd expression, as
well as DW35 carrying high-copy number plasmids encoding the
functional sdh operon, do not bind HOQNO and thus were not exam-
ined. Table 2 shows the WT Frd enzyme bound HOQNO with an ap-
parent dissociation constant (Kd) of 5 nM, consistent with previous
studies [36]. No change in the afﬁnity for HOQNO was observed in
the FrdB-S203R variant. All three FrdB-K228 variants, including
FrdB-K228R, caused the Kd value to increase more than 10-fold (80–
110 nM range) compared to the WT Frd enzyme, in agreement with
the role of FrdB-K228 in quinone binding [23].
3.4. EPR spectroscopy of the [3Fe–4S] cluster and heme b
The cofactors which are in closest proximity to the variants stud-
ied herein are the [3Fe–4S] clusters of Frd and Sdh, as well as the
heme b moiety of Sdh. The biophysical properties of these cofactors
were examined by EPR spectroscopy to probe structure–function re-
lationships in the SdhB/FrdB variants. The wild-type enzymes exhibit
broadly similar oxidized spectra corresponding to the [3Fe–4S] clus-
ter, comprising a peak at g = 2.02 and a trough immediately upﬁeld
which is signiﬁcantly broader in the case of FrdABCD [37]. In the
FrdB-K228E/L/R variants, the EPR line shapes of the [3Fe–4S] cluster
were narrower than that of the WT Frd enzyme, and is most notice-
able in the FrdB-K228L variant (note the position of the trough in
the absence of HOQNO in Fig. 3). In addition, the FrdB-K228R variant
also showed a distinct shoulder at g = 2.04 that is absent in the WT
signal. No major changes were observed in the oxidized spectra of
the SdhB-R205S, SdhB-K230L and FrdB-S203R variants (Figs. 3 and 4).ssay, succinate was used as electron donor and reduction of MTT was measured in the
ction and lapachol oxidation were monitored at varying concentrations of the quinone
–Menten equation using Solver and at least 8 activity measurements at different Q0 and
mounts of HOQNO until increases in ﬂuorescence were observed. This was repeated at
oncentration of binding sites and dissociation constants (Kd) can be determined. Error:
Lapachol:fumarate Kd, HOQNO
m (mM) kcat (s−1) Km (mM) (nM)
.15 11.9 0.10 ND
.22 5.1 0.10 ND
.17 9.2 0.07 ND
.06 126.1 0.22 5
.09 53.5 0.14 5
D 0.1 ND 110
D 0.1 ND 110











2.10 2.05 2.00 1.95 1.90
g-value
Fig. 3. EPR spectra of the oxidized [3Fe–4S] cluster in Frd. Membranes fromDW35 (i) and
those overexpressing WT Frd (ii), FrdB-S203R (iii), FrdB-K228E (iv), FrdB-K228L (v) and
FrdB-K228R (vi) were incubated for 5 min after addition of ethanol (thin lines) or
0.5 mM HOQNO/ethanol (thick lines), followed by addition of 0.2 mM ferricyanide and
incubating for 2 additional minutes. Spectral amplitudes were adjusted to the oxidized
WT Frd signals for comparison.
Table 3
Midpoint potentials of the [3Fe–4S] cluster and heme b. Redox titrations on membrane
preparations containing each construct were carried out at pH 7 and ﬁtted to the
Nernst equation. 200 μL samples poised at varying reduction potentials were frozen
with liquid nitrogen-chilled ethanol and analyzed by EPR. The signal at g = 2.02 was
used to determine the midpoint potential of the [3Fe–4S] cluster while the g = 3.66
signal was used for the heme b. Since Frd does not assemble a heme b cofactor, no
values were reported. The error in Em values is approximately ±10 mV.
[3Fe–4S] Heme b
WT Sdh +67 +10
SdhB-R205S +28 −24
SdhB-K230L +52 +25
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tion of HOQNO elicits an additional peak trough at g = 1.98 in the
[3Fe–4S] cluster signal that is speciﬁc to the Frd enzyme. As expected,
the addition of HOQNO to the FrdB-S203R mutant resulted in appear-
ance of a peak–trough signal; however, it is centered at g = 1.99.
Surprisingly, the peak–trough signal did not appear when we added
HOQNO to the FrdB-K228R and FrdB-K228E variants, but appeared
when HOQNO was added to the FrdB-K228L variant.
We also examined the oxidized heme b signal in the mutant Sdh
variants (Fig. 4B). The WT Sdh enzyme exhibits a broad signal that
comprises two overlapping peaks located at g = 3.66 and g = 3.55
[6,39,40]. In the SdhB-R205S variant, the two components observed
in the wild-type enzyme collapse into a single archetypal highly an-
isotropic low spin (HALS) heme spectrum with a single ramp-type
feature corresponding to gz [41,42]. Such an effect has previously
been observed in Sdh variants that affect the proton channel [39]
and the planarity of the heme [40]. No major changes were observed
in the oxidized heme spectrum of the SdhB-K230L variant.A 2.02
Fig. 4. EPR spectra of the oxidized [3Fe–4S] (A) and heme b (B) in Sdh. Spectra ofWTSdh (i), Sdh
fully oxidized (ambient potential poised at least 100 mV higher than the experimentally determ
nals for comparison.Finally, the reduction potentials (Em values) of the [3Fe–4S]
cluster and heme b were determined and are shown in Table 3. The
SdhB-R205S variant caused the Em values of the [3Fe–4S] cluster
and the heme b to decrease by 39 mV and 34 mV, respectively. The
reciprocal variant, FrdB-S203R, did not cause a change in the Em
value of the [3Fe–4S] cluster. The SdhB-K230L variant only caused
modest changes in the Em values of the [3Fe–4S] cluster and heme,
which were decreased by 15 mV and increased by 15 mV, respectively.
In Frd, mutation of the equivalent Lys residue resulted in much larger
variations in the Em value of the [3Fe–4S] cluster. The FrdB-K228R
variant, which likely retains a positive charge, elicited a modest
18 mV decrease in its Em value. The FrdB-K228E and FrdB-K228L vari-
ants, both of which eliminate a basic residue whose side chain interacts
with MQ and the backbone amide oxygen of FrdB-Cys104, caused
the Em value of the [3Fe–4S] cluster to decrease to −172 mV and
−177 mV, respectively.
4. Discussion
In this study, we examined the equivalent residues SdhB-R205 and
FrdB-S203, as well as the conserved pair SdhB-K230 and FrdB-K228.
These residues are located at the interface between the soluble and
membrane anchor domains and allow us to study: i) protein control
of cofactor midpoint potentials because of their close proximity to the
[3Fe–4S] cluster (and the heme b in Sdh), ii) quinone binding and
oxidation/reduction, and iii) differences in Sdh and Frd that lead to di-









B-R205S (ii) and SdhB-K230L (iii) were obtained during redox titrationswherein Sdhwas
inedmidpoint potential). Spectral amplitudeswere adjusted to the oxidizedWT Sdh sig-
1146 V.W.T. Cheng et al. / Biochimica et Biophysica Acta 1827 (2013) 1141–11474.1. FrdB-K228 and SdhB-K230
Based on the structural alignment depicted in Fig. 1 and the
H-bonding partners listed in Table 1, we hypothesized that quinone
binding and oxidation/reduction would be impaired in the FrdB-K228
variants. A previous study had shown that the FrdB-K228R and
FrdB-K228L variants were unable to reduce or oxidize exogenous qui-
none species [23]. In agreement, the FrdB-K228L variant examined
herein also had negligible succinate:Q0 and LPCH:fumarate activities.
The FrdB-K228R variant showed signiﬁcant loss of LPCH:fumarate ac-
tivity, but surprisingly retained signiﬁcant succinate:Q0 activity when
assayed in membranes (Table 2). Upon detergent treatment, the en-
zyme rapidly lost activity, consistent with the negligible activity (b1%)
observed with the puriﬁed enzyme [23]. In addition to the lack of
LPCH:fumarate activity shown here, the FrdB-K228R variant is also un-
able to utilizeMQ1H2 and UQ1 as substrates [23]. The decreased activity
of the FrdB-K228R membrane-bound enzyme may reﬂect an altered
pKa for the reaction since an Arg residue may have a higher pKa than
the Lys residue that is normally present. Overall, the loss of activity in
the FrdB-K228 variant enzymes suggests the importance of an amino
acid side chain with a basic pKa value at this position. The extended
H-bonding network involving FrdB-C204, FrdB-Q225, FrdD-W14, and
MQ (Supplemental Fig. 2A) most likely helps to decrease the pKa of
FrdB-K228 to allow proton exchange at physiological pH. We also ex-
amined whether the FrdB-K228 variants, similar to the FrdC-E29L vari-
ant, were trapped in an intermediary state during catalysis where the
menasemiquinone is stabilized [36,38]. However, inQ-pool coupling as-
says using dithionite–fumarate as the donor–acceptor pair, we did not
observe signiﬁcant increases in the semiquinone EPR spectra of the var-
iants (data not shown). The presence of the semiquinone EPR signal it-
self is in stark contrast to the experiments done on the E. coli respiratory
nitrate reductase, wherein mutation of a Lys residue that hydrogen
bonds to MQ/UQ abolishes the semiquinone signal in redox titrations
[43,44].
Mutation of FrdB-K228 also demonstrated that this residue plays a
pivotal role in deﬁning the biophysical properties of the [3Fe–4S] clus-
ter. The Glu/Leu/Arg variants all resulted in changes in the EPR line
shape of the oxidized [3Fe–4S] spectrum, which suggests subtle
changes in the H-bonding network andmicroenvironment surrounding
FrdB-K228, the [3Fe–4S] cluster and the MQ molecule. In addition, the
expected appearance of an EPR peak–trough signal at g = 1.98 upon
HOQNO addition is either attenuated or absent, consistent with the ob-
served increases in the Kd for HOQNO [34,36]. The FrdB-K228L and
FrdB-K228E variants also elicited large decreases in the Em values of
the [3Fe–4S] cluster (ΔEm = −110 mV and −105 mV respectively)
while only a moderate change was observed in the FrdB-K228R variant
(ΔEm = −18 mV). The magnitude of change in the Em value of the
[3Fe–4S] cluster in the FrdB-K228E/L variants is consistent with disrup-
tion of a H-bonding network connected to the iron–sulfur cluster and
the MQ molecule [17,45,46].
In Sdh, the conserved residue SdhB-K230 does not interact with the
Q-site. The residue was once thought to be a component of a proposed
H+ channel leading to the Q-site [47], but site-directed mutagenesis
and crystallography data suggest otherwise [39,48]. Not surprisingly,
we did not observe changes in catalytic activities in the SdhB-K230L
variant. It had been suggested that the redox properties of the [3Fe–4S]
cluster might be altered in the SdhB-K230L variant [48]. Indeed, given
that the FrdB-K228L variant removed an H-bond donor to FrdB-C204
(a ligand to the [3Fe–4S] cluster) and resulted in a 110 mV decrease in
the Em value of the [3Fe–4S], we would also expect the parallel mutation
in Sdh to yield a similar shift in Em value. However, we were surprised
that this variant only elicited a 15 mV decrease in the Em value of the
[3Fe–4S] cluster compared to theWT Sdh enzyme. Since the Lys residue
points into a hydrophilic milieu, the likely explanation is that additional
water molecules can ﬁll the void in the SdhB-K230L variant when the
amino group is removed.4.2. FrdB-S203 and SdhB-R205
We constructed the reciprocal mutations FrdB-S203R and SdhB-
R205S in hopes of replicating a recent study on the SdhB-H207/
FrdB-T205 pair that elicited an opposing effect on the [3Fe–4S] cluster
Em value [12]. Although the SdhB-R205S variant decreased the Em values
of both the [3Fe–4S] cluster and heme b, no change in the Em value of the
former was observed in the FrdB-S203R variant. The small changes in Em
values are consistentwithminor perturbationswithin the proteinmilieu
without disrupting the H-bonding network surrounding the [3Fe–4S]
cluster or the heme [12,39,40]. The SdhB-R205S variant also had a no-
ticeable effect on the EPR lineshape of the heme. The shift towards the
“sharp” species at g = 3.66 may be attributed to the heme adopting a
more planar, rather than a saddled or mixed, conformation [40]. We
have also shown that variants that perturb the H-bonding network in-
volving the water channel caused the low-spin oxidized heme b spec-
trum to shift towards the g = 3.66 species [39], as was observed here.
The Sdh structure (PDB: 1NEK) shows a distinct water channel
leading from the cytoplasm, through the enzyme, to the Q-site and
presumably acts as a proton shuttle for UQ reduction [3,47,48]. The
guanidinium side chain of SdhB-R203 forms H-bonds to the three ter-
minal water molecules (HOH310, HOH328, HOH319) closest to UQ in
the native structure, as well as to the side chain of SdhD-D82. The latter
residue is involved in a complex H-bonding network that also includes
SdhC-R31, SdhD-Y83 and UQ (Supplemental Fig. 2B), and its replace-
ment by Leu abolished 98% and 85% of succinate:Q0 and plumbagin:fu-
marate activities, respectively [28]. If the role of SdhB-R205 is to
stabilize the water molecules closest to UQ for H+ exchange, then this
explains why the SdhB-R205S variant caused a larger decrease in succi-
nate:Q0 activity than the FrdB-S203R variant. Given that both reciprocal
variants can catalyze in vitro reactions and complement the DW35
strain in vivo, it is obvious that this pair of equivalent residues is
non-essential for enzyme function. Furthermore, there does not appear
to be any correlation between enzyme turnover and the midpoint po-
tentials of any of the redox cofactors in Sdh and Frd.5. Conclusions
We have examined equivalent residues in Sdh and Frd which have
evolutionarily diverged (SdhB-R205/FrdB-S203) or remained con-
served (SdhB-K230/FrdB-K228). These two pairs of residues provide
an interesting insight into the bidirectional, but biased, enzymatic func-
tionalities of these two homologous enzymes because they are posi-
tioned between the highly conserved electron transfer subunit and
the highly variable membrane anchor domain. Although SdhB-K230
and FrdB-K228 have remained conserved throughout evolution, their
roles have clearly diverged, reﬂecting the different locations of the
Q-sites in Sdh and Frd. The former residue is a component of a water
network that may be involved in shuttling H+ towards the Q-site in
Sdh. In Frd, the Lys residue is involved in quinone binding; in addition,
the hydrogen bonding functionality of this residue to the backbone
amide bond oxygen of FrdB-C204 appears to be an important contribu-
tor in establishing the midpoint potential of the [3Fe–4S] cluster.Acknowledgements
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